On the benefits of silymarin in murine colitis by improving balance of destructive cytokines and reduction of toxic stress in the bowel cells

Central European Journal of Biology

Volumn 4, Issue 2, 2009, Pages 204-213

  Esmaily, Hadi ^a   Hosseini Tabatabaei, Azadeh ^a   Rahimian, Reza ^a   Khorasani, Reza ^a   Baeeri, Maryam ^a   Barazesh Morgani, Ahmadreza ^a   Yasa, Nargues ^b   Khademi, Yassaman ^a   Abdollahi, Mohammad ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Inflammatory bowel disease; Inflammatory cytokines; Malondialdehyde; Myeloperoxidase; Silymarin

Indexed keywords

ANIMALIA; MURINAE; RATTUS;

EID: 67349111659     PISSN: 1895104X     EISSN: 16443632     Source Type: Journal    
DOI: 10.2478/s11535-008-0053-2     Document Type: Article

References (53)

1. A. Hosseini-Tabatabaei M. Abdollahi 2008 Potassium channel openers and improvement of toxic stress: Do they have role in the management of inflammatory bowel disease? Inflamm. Allergy Drug Targets 7 129 135
2. T. Kucharzik C. Maaser A. Lügering M. Kagnoff L. Mayer S. Targan 2006 Recent understanding of IBD pathogenesis: implications for future therapies Inflamm. Bowel Dis. 12 1068 1083 (Pubitemid 44665477)
3. F. Scaldaferri C. Fiocchi 2007 Inflammatory bowel disease: progress and current concepts of etiopathogenesis J. Dig. Dis. 8 171 178
4. A. Rezaie R.D. Parker M. Abdollahi 2007 Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause? Dig. Dis. Sci. 52 2015 2021 (Pubitemid 47246507)
5. O. Blokhina E. Virolainen K.V. Fagerstedt 2003 Antioxidants, oxidative damage and oxygen deprivation stress: a review Ann. Bot. (Lond.) 91 179 194 (Pubitemid 36117177)
6. D.A. Wink K.M. Miranda M.G. Espey 2001 Cytotoxicity related to oxidative and nitrosative stress by nitric oxide Exp. Biol. Med. 226 621 623 (Pubitemid 32619597)
7. M. Nayar J.M. Rhodes 2004 Management of inflammatory bowel disease Postgrad. Med. J. 80 206 213 (Pubitemid 38561400)
8. L. Langmead D.S. Rampton 2006 Review article: complementary and alternative therapies for inflammatory bowel disease, Aliment Pharmacol. Ther. 23 341 349 (Pubitemid 43382014)
9. M.C. Dubinsky 2004 Targeting therapy in pediatric inflammatory bowel disease Curr. Treat Options Gastroenterol. 7 391 405 (Pubitemid 39467909)
10. F. Ebrahimi H. Esmaily M. Baeeri A. Mohammadirad S. Fallah M. Abdollahi 2008 Molecular evidences on the benefits of N-acetylcysteine in experimental colitis Cent. Eur. J. Biol. 3 135 142
11. Hosseini-Tabatabaei A., Esmaily H., Rahimian R., Khorasani R., Baeeri M., Barazesh-Morgani A., et al., Benefits of nicorandil using an immunologic murine model of experimental colitis, Cent. Eur. J. Biol., [Epub ahead of print], DOI: 10.2478/s11535-008-0047-0
12. B. Elahi S. Nikfar S. Derakhshani M. Vafaie M. Abdollahi 2007 On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: A meta-analysis of controlled clinical trials Dig. Dis. Sci. 53 1278 1284
13. A. Rezaie B. Taghavi-Bayat M. Abdollahi 2005 Biologic management of fistulizing Crohn's disease Int. J. Pharmacol. 1 17 24
14. R. Rahimi S. Nikfar A. Rezaie M. Abdollahi 2008 A metaanalysis of the benefit of probiotics in maintaining remission of human ulcerative colitis: evidence for prevention of disease relapse and maintenance of remission Arch. Med. Sci. 4 185 190
15. R. Rahimi S. Nikfar F. Rahimi 2008 A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease Dig. Dis. Sci. 53 2524 2531
16. R. Rahimi S. Nikfar A. Rezaie M. Abdollahi 2007 A metaanalysis of antibiotic therapy for active ulcerative colitis Dig. Dis. Sci. 52 2920 2925 (Pubitemid 47512546)
17. R. Rahimi S. Nikfar A. Rezaie M. Abdollahi 2006 A meta-analysis of broad spectrum antibiotic therapy in patients with active Crohn's disease Clin. Ther. 28 1983 1988 (Pubitemid 46215747)
18. Nikfar S., Rahimi R., Rezaie A., Abdollahi M., A meta-analysis of the efficacy of sulfasalazine in comparison with 5-aminosalicylates in the induction of improvement and maintenance of remission in patients with ulcerative colitis, Dig. Dis. Sci., 2008 [Epub ahead of print], DOI: 10.1007/s10620-008- 0481-x
19. Rahimi R., Nikfar S., Rezaie A., Abdollahi M., Comparison of mesalazine and balsalazide in induction and maintenance of remission in patients with ulcerative colitis: A meta-analysis, Dig. Dis. Sci., 2008 [Epub ahead of print], DOI: 10.1007/s10620-008-0428-2
20. R. Rahimi S. Nikfar A. Rezaie M. Abdollahi 2008 Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a meta-analysis Reprod. Toxicol. 25 271 275
21. L. Ashtaral-Nakhai A. Mohammadirad N. Yasa B. Minaie S. Nikfar G. Ghazanfari 2007 Benefits of Zataria multiflora boiss in experimental model of mouse inflammatory bowel disease Evid. Based Complement. Alternat. Med. 4 43 50 (Pubitemid 46410877)
22. H. Ghafari N. Yasa A. Mohammadirad G. Dehghan M.J. Zamani S. Nikfar 2006 Protection by Ziziphora clinopoides of acetic acid-induced toxic bowel inflammation through reduction of cellular lipid peroxidation and myeloperoxidase activity Hum. Exp. Toxicol. 25 325 332 (Pubitemid 44064967)
23. G. Ghazanfari B. Minaie N. Yasa L. Nakhai A. Mohammadirad S. Nikfar 2006 Biochemical and histopathological evidences for beneficial effects of Satureja khuzestanica jamzad essential oil on the mouse model of inflammatory bowel diseases Toxicol. Mech. Methods 16 365 372 (Pubitemid 44087001)
24. Rahimi R., Mozaffari S., Abdollahi M., On the use of herbal medicines in management of inflammatory bowel diseases: A systematic review of animal and human studies, Dig. Dis. Sci., 2008 [Epub ahead of print], DOI: 10.1007/s10620-008-0368-x
25. S.C. Pradhan C. Girish 2006 Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine Indian. J. Med. Res. 124 491 504 (Pubitemid 46157708)
26. H.Z. Toklu T. Tunali Akbay A. Velioglu-Ogunc F. Ercan N. Gedik M. Keyer-Uysal 2008 Silymarin, the antioxidant component of Silybum marianum, prevents sepsis-induced acute lung and brain injury J. Surg. Res. 145 214 222
27. F. Rainone 2005 Milk thistle Am. Fam. Physician. 72 1285 1288 (Pubitemid 43104260)
28. R. Gazák D. Walterová V. Kren 2007 Silybin and silymarin-new and emerging applications in medicine Curr. Med. Chem. 14 315 338 (Pubitemid 46313027)
29. S. Luper 1998 A review of plants used in the treatment of liver disease: part 1 Altern. Med. Rev. 3 410 421 (Pubitemid 128709687)
30. J.S. Kang Y.J. Jeon S.K. Park K.H. Yang H.M. Kim 2004 Protection against lipopolysaccharide-induced sepsis and inhibition of interleukin-1beta and prostaglandin E2 synthesis by silymarin Biochem. Pharmacol. 67 175 181 (Pubitemid 37518545)
31. F. Sanchez-Muñoz A. Dominguez-Lopez J.K. Yamamoto-Furusho 2008 Role of cytokines in inflammatory bowel disease World J. Gastroenterol. 14 4280 4288
32. J.S. Kang Y.J. Jeon H.M. Kim S.H. Han K.H. Yang 2002 Inhibition of inducible nitric-oxide synthase expression by silymarin in lipopolysaccharidestimulated macrophages J. Pharmacol. Exp. Ther. 302 138 144 (Pubitemid 34680431)
33. M.D. Barrachina J. Panés J.V. Esplugues 2001 Role of nitric oxide in gastrointestinal inflammatory and ulcerative diseases: perspective for drugs development Curr. Pharm. Des. 7 31 48 (Pubitemid 32409706)
34. G. Jahanshahi V. Motavasel A. Rezaie A.A. Hashtroudi N.E. Daryani M. Abdollahi 2004 Alterations in antioxidant power and levels of epidermal growth factor and nitric oxide in saliva of patients with inflammatory bowel diseases Dig. Dis. Sci. 49 1752 1757 (Pubitemid 40228532)
35. S.K. Manna A. Mukhopadhyay N.T. Van B.B. Aggarwal 1999 Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis J. Immunol. 163 6800 6809
36. P. Angulo R.A. Jorgensen K.V. Kowdley K.D. Lindor 2008 Silymarin in the treatment of patients with primary sclerosing cholangitis: an open-label pilot study Dig. Dis. Sci. 53 1716 1720
37. R. Saller R. Meier R. Brignoli 2001 The use of silymarin in the treatment of liver diseases. Drugs 61 2035 2063 (Pubitemid 33135182)
38. M. Abdollahi A.R. Dehpour G. Baharnouri 1998 Alteration by rubidium of rat submandibular secretion of protein and N-acetyl -D-glucosaminidase Toxic. Subst. Mech. 17 121 131 (Pubitemid 28180816)
39. J.L. Wallace C.M. Keenan D. Gale T.S. Shoupe 1992 Exacerbation of experimental colitis by nonsteroidal anti-inflammatory drugs is not related to elevated leukotriene B4 synthesis Gastroenterology 102 18 27
40. G. Dehghan A. Shafiee M.H. Ghahremani S.K. Ardestani M. Abdollahi 2007 Antioxidant potential of various extracts from ferula szovitsiana in relation to their phenolic content, Pharm Biol.. 45 691 699 (Pubitemid 350125760)
41. F. Astaneie M. Afshari A. Mojtahedi S. Mostafalou M.J. Zamani B. Larijani 2005 Total antioxidant capacity and levels of epidermal growth factor and nitric oxide in blood and saliva of insulin-dependent diabetic patients Arch. Med. Res. 36 376 381 (Pubitemid 40798392)
42. O.H. Lowry N.J. Rosebrough A.L. Farr R.J. Randall 1951 Protein measurement with the Folin phenol reagent J. Biol. Chem. 193 265 275
43. M.I. Torres M. García-Martin M.I. Fernández N. Nieto A. Gil A. Ríos 1999 Experimental colitis induced by trinitrobenzenesulfonic acid: an ultrastructural and histochemical study Dig. Dis. Sci. 44 2523 2529 (Pubitemid 30027371)
44. M. Kolgazi N. Jahovic M. Yüksel F. Ercan I. Alican 2007 α-lipoic acid modulates gut inflammation induced by trinitrobenzene sulfonic acid in rats J. Gastroenterol. Hepatol. 22 1859 1865 (Pubitemid 47525046)
45. A.R. Jurjus N.N. Khoury J.M. Reimund 2004 Animal models of inflammatory bowel disease J. Pharmacol. Toxicol. Method. 50 81 92 (Pubitemid 39286320)
46. C. Shen G. De Hertogh D.M. Bullens G. Van Assche K. Geboes P. Rutgeerts 2007 Remissioninducing effect of anti-TNF monoclonal antibody in TNBS colitis: mechanisms beyond neutralization? Inflamm. Bowel Dis. 13 308 316 (Pubitemid 46465912)
47. R. Rahimi S. Nikfar M. Abdollahi 2007 Do anti-tumor necrosis factors induce response and remission in patients with acute refractory Crohn's disease? A systematic meta-analysis of controlled clinical trials Biomed. Pharmacother. 61 75 80 (Pubitemid 46185874)
48. R. Rahimi S. Nikfar M. Abdollahi 2007 Meta-analysis technique confirms the effectiveness of anti-TNF-alpha in the management of active ulcerative colitis when administered in combination with corticosteroids Med. Sci. Monit. 13 PI13 PI18 (Pubitemid 47037680)
49. N.J. Simmonds D.S. Rampton 1993 Inflammatory bowel disease - a radical view Gut 34 865 868 (Pubitemid 23203102)
50. G. Rogler T. Andus 1998 Cytokines in inflammatory bowel disease World J. Surg. 22 382 389 (Pubitemid 28113526)
51. S. Grulke T. Franck M. Gangl F. Péters A. Salciccia G. Deby-Dupont 2008 Myeloperoxidase assay in plasma and peritoneal fluid of horses with gastrointestinal disease Can. J. Vet. Res. 72 37 42
52. L. Kruidenier I. Kuiper C.B. Lamers H.W. Verspaget 2003 Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants J. Pathol. 201 28 36 (Pubitemid 37121200)
53. T. Cruz J. Gμlvez E. Crespo M.A. Ocete A. Zarzuelo 2001 Effects of silymarin on the acute stage of the trinitrobenzenesulphonic acid model of rat colitis Planta Med. 67 94 96 (Pubitemid 32199958)